3rd Quarter - Amendment

ALLERGAN, INC. for ALLERGAN, INC.

Firm
Client
Income
—
Expenses
$400,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2008 $460,000 Replaced
3rd Quarter - Amendment (this page) Jun 19, 2009 $400,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

HR5629: PATHWAY FOR BIOSIMILARS ACT.; PROVISIONS ON FOLLOW-ON BIOLOGICALS

LobbyistCovered position, as disclosed
W BRADFORD GARY N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5629 (110th)

Taxation/Internal Revenue Code TAX

HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT

LobbyistCovered position, as disclosed
W BRADFORD GARY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6049 (110th), H.R. 7060 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.